Suk-Chan Jang, PharmD, PhD
Post-Doctoral Associate
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 246-3768
Business Email:
sukchan.jang@ufl.edu
Board Certifications
-
Registered PharmacistMinistry of Health and Welfare, Republic of Korea
Publications
Academic Articles
2024
A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma
Frontiers in Oncology.
14
[DOI] 10.3389/fonc.2024.1282323.
[PMID] 38361777.
2022
Clinical impact and economic burden of post-transplant infections following heart transplantation: A retrospective nationwide cohort study
The Journal of Heart and Lung Transplantation.
41(11):1601-1610
[DOI] 10.1016/j.healun.2022.08.001.
2022
Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis
Orphanet Journal of Rare Diseases.
17(1)
[DOI] 10.1186/s13023-022-02425-3.
[PMID] 35840997.
2022
Optimal Indicator of Death for Using Real-World Cancer Patients’ Data From the Healthcare System
Frontiers in Pharmacology.
13
[DOI] 10.3389/fphar.2022.906211.
[PMID] 35784684.
2021
Association between oseltamivir use and neuropsychiatric adverse events in influenza patients: a nationwide population-based cohort study
Expert Opinion on Drug Safety.
20(2):245-253
[DOI] 10.1080/14740338.2021.1850690.
2020
National Research and Development Trends related to Safety Evaluation Technology of Biologics and Chemical Synthetic Drug: A Network Analysis
Yakhak Hoeji.
64(4):290-298
[DOI] 10.17480/psk.2020.64.4.290.
Education
PhD in Pharmaceutical Outcomes & Policy
2022
·
Sungkyunkwan University (SKKU)
Doctor of Pharmacy
2018
·
Sungkyunkwan University (SKKU)
Contact Details
Phones:
- Business:
- (352) 246-3768
Emails:
- Business:
- sukchan.jang@ufl.edu
Addresses:
- Business Street:
-
1225 Center Drive
GAINESVILLE FL 32611